title:: US9931790B2 — Method and system for advanced transcatheter aortic valve implantation planning
patent:: US9931790B2
status:: granted 2018-04-03 · Active
filed:: 2015-04-16
assignee:: Siemens Healthcare GmbH
people:: Sasa Grbic, Razvan Ionasec, Tommaso Mansi, Ingmar Voigt, Dominik Neumann, Julian Krebs, Chris Schwemmer, Max Schoebinger, Helene C. Houle, Dorin Comaniciu, Joel Mancina
domain:: Industrial Systems, Data Engineering, Cardiology, Computational Modeling
link:: https://patents.google.com/patent/US9931790B2/en
Figure 1 from the published patent document. Patent drawings are public records.
Abstract
A method and system for transcatheter aortic valve implantation (TAVI) planning is disclosed. An anatomical surface model of the aortic valve is estimated from medical image data of a patient. Calcified lesions within the aortic valve are segmented in the medical image data. A combined volumetric model of the aortic valve and calcified lesions is generated. A 3D printed model of the heart valve and calcified lesions is created using a 3D printer. Different implant device types and sizes can be placed into the 3D printed model of the aortic valve and calcified lesions to select an implant device type and size for the patient for a TAVI procedure. The method can be similarly applied to other heart valves for any type of heart valve intervention planning.
Data Points
- US9931790B2 — granted US patent (kind code B2)
- Filed 2015-04-16, granted 2018-04-03
- Legal status today — Active
- Assignee — Siemens Healthcare GmbH
- Co-inventors — Sasa Grbic, Tommaso Mansi, Ingmar Voigt, Dominik Neumann, Julian Krebs, Chris Schwemmer, Max Schoebinger, Helene C. Houle, Dorin Comaniciu, Joel Mancina
Part of the complete record in Patents.
